Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 9, 2015, Pages 5455-5462

  Cuevas Córdoba, Betzaida ^a   Juárez Eusebio, Dulce María ^d   Almaraz Velasco, Raquel ^d   Muñiz Salazar, Raquel ^b   Laniado Laborin, Rafael ^c   Zenteno Cuevas, Roberto ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c Instituto de Servicios de Salud Pública de Baja California   (Mexico)

^d UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; EMBB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GLYCOSYLTRANSFERASE; TUBERCULOSTATIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; CODON; CONTROLLED STUDY; DIABETES MELLITUS; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; EMBB GENE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEXICO; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION;

ANTITUBERCULAR AGENTS; ETHAMBUTOL; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PENTOSYLTRANSFERASES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84940948928     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00117-15     Document Type: Article

References (43)

1. World Health Organization (WHO). 2014. Global tuberculosis report 2014. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/global-report/gtbr14-main-text.pdf.
2. World Health Organization (WHO). 2014. Drug-resistant TB: surveillance & response. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/global-report/gtbr14-supplement-web-v3.pdf.
3. Blanc LCP, Espinal M, Graham S, Grzemska M, Harries A, Luelmo F, Maher D, O'Brien R, Raviglione M, Rieder H, Starke J, Uplekar M, Wells C. 2003. Treatment of tuberculosis: guidelines for national programs, 3rd ed. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/2003/who-cds-tb-2003.313-eng.pdf.
4. Mikusova K, Slayden RA, Besra GS, Brennan PJ 1995. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 39:2484-2489. http://dx.doi.org/10.1128/AAC.39.11.2484.
5. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR, Jr. 1997. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3:567-570.
6. Berg S, Starbuck J, Torrelles JB, Vissa VD, Crick DC, Chatterjee D, Brennan PJ 2005. Roles of conserved proline and glycosyltransferase motifs of embC in biosynthesis of lipoarabinomannan. J Biol Chem 280: 5651-5663. http://dx.doi.org/10.1074/jbc.M411418200.
7. Escuyer VE, Lety MA, Torrelles JB, Khoo KH, Tang JB, Rithner CD, Frehel C, McNeil MR, Brennan PJ, Chatterjee D. 2001. The role of the embAandembBgene productsinthe biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J Biol Chem 276:48854-48862. http://dx.doi.org/10.1074/jbc.M102272200.
8. Zhang N, Torrelles JB, McNeil MR, Escuyer VE, Khoo KH, Brennan PJ, Chatterjee D. 2003. The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol Microbiol 50:69-76. http://dx.doi.org/10.1046/j.1365-2958.2003.03681.x.
9. Alcaide F, Pfyffer GE, Telenti A. 1997. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 41:2270-2273.
10. Escalante P, Ramaswamy S, Sanabria H, Soini H, Pan X, Valiente-Castillo O, Musser JM 1998. Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuber Lung Dis 79:111-118. http://dx.doi.org/10.1054/tuld.1998.0013.
11. Lee AS, Othman SN, Ho YM, Wong SY 2004. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 48:4447-4449. http://dx.doi.org/10.1128/AAC.48.11.4447-4449.2004.
12. Lee HY, Myoung HJ, Bang HE, Bai GH, Kim SJ, Kim JD, Cho SN 2002. Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol. Yonsei Med J 43:59-64. http://dx.doi.org/10.3349/ymj.2002.43.1.59.
13. Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW. 2005. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 49:2218-2225. http://dx.doi.org/10.1128/AAC.49.6.2218-2225.2005.
14. Plinke C, Rüsch-Gerdes S, Niemann S. 2006. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 50:1900-1902. http://dx.doi.org/10.1128/AAC.50.5.1900-1902.2006.
15. Ramaswamy S, Musser JM 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79:3-29. http://dx.doi.org/10.1054/tuld.1998.0002.
16. Ramaswamy SV, Amin AG, Goksel S, Stager CE, Dou SJ, El Sahly H, Moghazeh SL, Kreiswirth BN, Musser JM 2000. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44:326-336. http://dx.doi.org/10.1128/AAC.44.2.326-336.2000.
17. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA 2004. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 53:107-113. http://dx.doi.org/10.1099/jmm.0.05343-0.
18. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR, Jr, Telenti A, Musser JM. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 41:1677-1681.
19. Sugawara I, Otomo K, Yamada H, Wang G, Du C, Shi R, Zhang G. 2005. The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China. Jpn J Infect Dis 58:393-395.
20. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, Simpson J, Gie RP, Enarson DA, Beyers N, van Helden PD, Victor TC. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39:636-641. http://dx.doi.org/10.1128/JCM.39.2.636-641.2001.
21. Hazbon MH, Bobadilla del Valle M, Guerrero MI, Varma-Basil M, Filliol I, Cavatore M, Colangeli R, Safi H, Billman-Jacobe H, Lavender C, Fyfe J, Garcia-Garcia L, Davidow A, Brimacombe M, Leon CI, Porras T, Bose M, Chaves F, Eisenach KD, Sifuentes-Osornio J, Ponce de Leon A, Cave MD, Alland D. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 49:3794-3802. http://dx.doi.org/10.1128/AAC.49.9.3794-3802.2005.
22. Perdigao J, Macedo R, Ribeiro A, Brum L, Portugal I. 2009. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int J Antimicrob Agents 33:334-338. http://dx.doi.org/10.1016/j.ijantimicag.2008.09.021.
23. Post FA, Willcox PA, Mathema B, Steyn LM, Shean K, Ramaswamy SV, Graviss EA, Shashkina E, Kreiswirth BN, Kaplan G. 2004. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis 190:99-106. http://dx.doi.org/10.1086/421501.
24. Tracevska T, Jansone I, Nodieva A, Marga O, Skenders G, Baumanis V. 2004. Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol 155:830-834. http://dx.doi.org/10.1016/j.resmic.2004.06.007.
25. Guerrero E, Lemus D, Yzquierdo S, Vilchez G, Muñoz M, Montoro E, Takiff H. 2013. Association between embB mutations and ethambutol resistance in Mycobacterium tuberculosis isolates from Cuba and the Dominican Republic: reproducible patterns and problems. Rev Argent Microbiol 45:21-26.
26. Shen X, Shen GM, Wu J, Gui XH, Li X, Mei J, DeRiemer K, Gao Q. 2007. Association betweenembBcodon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 51:2618-2620. http://dx.doi.org/10.1128/AAC.01516-06.
27. Shi D, Li L, Zhao Y, Jia Q, Li H, Coulter C, Jin Q, Zhu G. 2011. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China. J Antimicrob Chemother 66:2240-2247. http://dx.doi.org/10.1093/jac/dkr284.
28. van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 29:2578-2586.
29. Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, Akrim M, Victor TC, El Mzibri M. 2009. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries 3:278-284.
30. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho ML, Martin C, Martin C, Mokrousov I, Marvskaïa O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Rüsch-Gerdes S, Sajduda A, Samper S, Shemyakin IG, et al. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6:23. http://dx.doi.org/10.1186/1471-2180-6-23.
31. Driscoll JR. 2009. Spoligotyping for molecular epidemiology of the Mycobacterium tuberculosis complex. Methods Mol Biol 551:117-128. http://dx.doi.org/10.1007/978-1-60327-999-4-10.
32. Demay C, Liens B, Burguiere T, Hill V, Couvin D, Millet J, Mokrousov I, Sola C, Zozio T, Rastogi N. 2012. SITVITWEB - a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 12: 755-766. http://dx.doi.org/10.1016/j.meegid.2012.02.004.
33. Pan American Health Organization (PAHO). 2013. Tuberculosis in the Americas. Regional report 2012: epidemiology, control and financing. Pan American Health Organization, Washington, DC. http://www.paho.org/hq/index.php?option=com-docman&task=doc-view&gid=22953&Itemid=.
34. Zenteno-Cuevas R, Rubi A, Fuentes-Dominguez J, Lara-Gonzalez JL, Escobar-Mesa A. 2010. Dynamics of multidrug resistant tuberculosis in Veracruz, Mexico between 2002 and 2008. J Infect Dev Ctries 4:776-778.
35. Castellanos-Joya M G-AM, Romero-Perez R, Martínez-Olivares ML. 2014. El control de la TB en México⋯ endondeestamos? 2014⋯ añode la detección tratamiento y curación delos enfermos de tuberculosis. Secretaríade Salud, Santiago de Querétaro, Mexico. http://www.cenaprece.salud.gob.mx/programas/interior/micobacteriosis/descargas/pdf/controlTbMexico-DrMartinCastellanos.pdf
36. Martinez-Guarneros A, Rastogi N, Couvin D, Escobar-Gutierrez A, Rossi LM, Vazquez-Chacon CA, Rivera-Gutierrez S, Lozano D, Vergara-Castañeda A, Gonzalez-Merchand JA, Vaughan G. 2013. Genetic diversity among multidrug-resistant Mycobacterium tuberculosis strains in Mexico. Infect Genet Evol 14:434-443. http://dx.doi.org/10.1016/j.meegid.2012.12.024.
37. Zenteno-Cuevas R, Cuevas-Córdoba B, Enciso A, Enciso L, Cuellar A. 2012. Assessing the utility of three TaqMan probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in Veracruz, Mexico. Can J Microbiol 58:318-325. http://dx.doi.org/10.1139/w11-127.
38. Srivastava S, Ayyagari A, Dhole TN, Nyati KK, Dwivedi SK 2009. emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol. Int J Med Microbiol 299: 269-280. http://dx.doi.org/10.1016/j.ijmm.2008.07.001.
39. Safi H, Lingaraju S, Amin A, Kim S, Jones M, Holmes M, McNeil M, Peterson SN, Chatterjee D, Fleischmann R, Alland D. 2013. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes. Nat Genet 45:1190-1197. http://dx.doi.org/10.1038/ng.2743.
40. Plinke C, Cox HS, Zarkua N, Karimovich HA, Braker K, Diel R, Rusch-Gerdes S, Feuerriegel S, Niemann S. 2010. embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. J Antimicrob Chemother 65:1359-1367. http://dx.doi.org/10.1093/jac/dkq120.
41. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB 2009. Tuberculosis drug resistance mutation database. PLoS Med 6:e2. http://dx.doi.org/10.1371/journal.pmed.1000002.
42. Zhang Z, Wang Y, Pang Y, Kam KM 2014. Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 52:638-641. http://dx.doi.org/10.1128/JCM.02713-13.
43. Safi H, Sayers B, Hazbon MH, Alland D. 2008. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 52:2027-2034. http://dx.doi.org/10.1128/AAC.01486-07.